• Corticotropin Releasing Hormone (CRH)
  • Mycobacterium tuberculosis Complex, Pyrazinamide (Isoniazid, rifampin) Resistance by pncA DNA Sequencing
  • West Nile Virus (WNV) Antibody, IgG and IgM
  • Alveolar Rhabdomyosarcoma (ARMS), 13q14 (FOXO1 or FKHR) Rearrangement, FISH, Tissue
  • Vimentin, IHC
  • HER2/neu (ERBB2), IHC, Semi-Quantitative, Other Tissue
  • Biopsy, Frozen Section
  • Zaleplon, Urine
  • Folic Acid (Folate), RBC
  • Epstein-Barr Virus (EBV) VCA, IgM
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Interpretation
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.
Loading...